Brain-Permeable Immunoproteasome-Targeting Macrocyclic Peptide Epoxyketones for Alzheimer’s Disease-Reference-Cited by-同舟云学术

Brain-Permeable Immunoproteasome-Targeting Macrocyclic Peptide Epoxyketones for Alzheimer’s Disease

Published:2024-04-18 Issue:9 Volume:67 Page:7146-7157
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Park Ji Eun¹,Chaudhary Chhabi Lal²,Bhattarai Deepak²,Kim Kyung Bo¹³^ORCID

Affiliation:

1. Center for Translational Science, Florida International University, 11350 SW Village Pkwy, Port St. Lucie, Florida 34987, United States

2. Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 S. Limestone, Lexington, Kentucky 40508, United States

3. Department of Cellular and Molecular Medicine, Herbert Wertheim College of Medicine, Florida International University, 11200 SW Eighth Street, Miami, Florida 33199, United States

Funder

National Institute on Aging

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c02488

Reference39 articles.

1. Global estimates on the number of persons across the Alzheimer's disease continuum

2. 2023 Alzheimer's disease facts and figures

3. Neuroinflammation in Alzheimer's disease

4. Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?

5. Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer’s disease: Rational insights for the therapeutic approaches

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Microglial Immunoproteasome: A Novel Approach in Neuroinflammatory-Related Disorders;ACS Chemical Neuroscience;2024-07-06